BACKGROUND: A large body of evidence suggests that immune system dysregulation is associated with Major Depressive Disorder (MDD) in adults. This study extends this work to adolescent MDD to examine the hypotheses of immune system dysregulation in adolescents with MDD, as manifested by significantly: (i) elevated plasma levels of cytokines (interferon [IFN]-gamma, tumor necrosis factor-alpha, interleukin [IL]-6, IL-1beta, and IL-4); and (ii) Th1/Th2 cytokine imbalance shifted toward Th1 as indexed by increased IFN-gamma/IL-4. METHOD: Thirty adolescents with MDD (19 females; 13 medication-free/naïve; ages 12-19) of at least 6 weeks duration and a minimum severity score of 40 on the Children's Depression Rating Scale-Revised, and 15 healthy comparisons (8 females), group-matched for age, were enrolled. Plasma cytokines were examined using enzyme-linked immunosorbent assay. Mann-Whitney test was used to compare subjects with MDD and controls. RESULTS: Adolescents with MDD had significantly elevated plasma IFN-gamma levels (3.38+/-11.8 pg/ml versus 0.37+/-0.64 pg/ml; p<0.003), and IFN-gamma/IL-4 ratio (16.6+/-56.5 versus 1.76+/-2.28; p=0.007). A trend for IL-6 to be elevated in the MDD group was also observed (1.52+/-2.88 pg/ml versus 0.49+/-0.90 pg/ml; p=0.09). Importantly, findings remained evident when medicated subjects were excluded. CONCLUSIONS: Findings suggest that immune system dysregulation may be associated with adolescent MDD, with an imbalance of Th1/Th2 shifted toward Th1, as documented in adult MDD. Larger studies with medication-free adolescents should follow.
BACKGROUND: A large body of evidence suggests that immune system dysregulation is associated with Major Depressive Disorder (MDD) in adults. This study extends this work to adolescent MDD to examine the hypotheses of immune system dysregulation in adolescents with MDD, as manifested by significantly: (i) elevated plasma levels of cytokines (interferon [IFN]-gamma, tumor necrosis factor-alpha, interleukin [IL]-6, IL-1beta, and IL-4); and (ii) Th1/Th2 cytokine imbalance shifted toward Th1 as indexed by increased IFN-gamma/IL-4. METHOD: Thirty adolescents with MDD (19 females; 13 medication-free/naïve; ages 12-19) of at least 6 weeks duration and a minimum severity score of 40 on the Children's Depression Rating Scale-Revised, and 15 healthy comparisons (8 females), group-matched for age, were enrolled. Plasma cytokines were examined using enzyme-linked immunosorbent assay. Mann-Whitney test was used to compare subjects with MDD and controls. RESULTS: Adolescents with MDD had significantly elevated plasma IFN-gamma levels (3.38+/-11.8 pg/ml versus 0.37+/-0.64 pg/ml; p<0.003), and IFN-gamma/IL-4 ratio (16.6+/-56.5 versus 1.76+/-2.28; p=0.007). A trend for IL-6 to be elevated in the MDD group was also observed (1.52+/-2.88 pg/ml versus 0.49+/-0.90 pg/ml; p=0.09). Importantly, findings remained evident when medicated subjects were excluded. CONCLUSIONS: Findings suggest that immune system dysregulation may be associated with adolescent MDD, with an imbalance of Th1/Th2 shifted toward Th1, as documented in adult MDD. Larger studies with medication-free adolescents should follow.
Authors: D L Musselman; D H Lawson; J F Gumnick; A K Manatunga; S Penna; R S Goodkin; K Greiner; C B Nemeroff; A H Miller Journal: N Engl J Med Date: 2001-03-29 Impact factor: 91.245
Authors: Flavio Kapczinski; Eduard Vieta; Ana Cristina Andreazza; Benicio N Frey; Fabiano A Gomes; Juliana Tramontina; Marcia Kauer-Sant'anna; Rodrigo Grassi-Oliveira; Robert M Post Journal: Neurosci Biobehav Rev Date: 2007-11-28 Impact factor: 8.989
Authors: Thomas Pollmächer; Monika Haack; Andreas Schuld; Abraham Reichenberg; Raz Yirmiya Journal: Brain Behav Immun Date: 2002-10 Impact factor: 7.217
Authors: S Fujigaki; K Saito; K Sekikawa; S Tone; O Takikawa; H Fujii; H Wada; A Noma; M Seishima Journal: Eur J Immunol Date: 2001-08 Impact factor: 5.532
Authors: Arthur R Van Gool; Durk Fekkes; Wim H J Kruit; Paul G H Mulder; Timo L M Ten Hagen; Marjolein Bannink; Michael Maes; Alexander M M Eggermont Journal: Psychiatry Res Date: 2003-07-15 Impact factor: 3.222
Authors: Steven J Schleifer; Jacqueline A Bartlett; Steven E Keller; Haftan M Eckholdt; Samuel C Shiflett; Beverly R Delaney Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-09 Impact factor: 8.829
Authors: Vilma Gabbay; Barbara J Coffey; Leah E Guttman; Lev Gottlieb; Yisrael Katz; James S Babb; Mia M Hamamoto; Charles J Gonzalez Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2009-05-07 Impact factor: 5.067
Authors: Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay Journal: World J Biol Psychiatry Date: 2018-08-16 Impact factor: 4.132
Authors: Adriana Di Martino; Damien A Fair; Clare Kelly; Theodore D Satterthwaite; F Xavier Castellanos; Moriah E Thomason; R Cameron Craddock; Beatriz Luna; Bennett L Leventhal; Xi-Nian Zuo; Michael P Milham Journal: Neuron Date: 2014-09-17 Impact factor: 17.173
Authors: Vilma Gabbay; Rachel G Klein; Leah E Guttman; James S Babb; Carmen M Alonso; Melissa Nishawala; Yisrael Katz; Marta R Gaite; Charles J Gonzalez Journal: J Child Adolesc Psychopharmacol Date: 2009-08 Impact factor: 2.576